Evidence map›Paper›PMID 40394876›Full record

ArticleThe American journal of case reports2025

Isopropyl Alcohol in Bleb Revision: A Novel Approach for Aesthetic and Functional Success.

Dania Bamefleh, Faisal A Altahan, Mehenaz Hanbazazh

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dania BameflehDepartment of Ophthalmology, Glaucoma Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.ORCID 0000-0001-6014-6931
Faisal A AltahanDepartment of Ophthalmology, Dhahran Eye Specialist Hospital, Dhahran, Saudi Arabia.ORCID 0000-0002-5317-128X
Mehenaz HanbazazhDepartment of Pathology, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Overhanging filtering blebs (OFB) are a known complication of trabeculectomy, leading to visual disturbances, discomfort, and cosmetic concerns. Their management remains challenging, with high recurrence rates despite surgical interventions. This case report presents the clinical course, management, and outcome of an 18-year-old woman with an OFB who underwent bleb revision incorporating isopropyl alcohol as an adjunctive measure. CASE REPORT An 18-year-old woman with a history of trabeculectomy and prior bleb revision presented with a large, cystic, overhanging filtering bleb that extended toward the cornea, causing cosmetic concerns and discomfort. Her best-corrected visual acuity (BCVA) was 20/100 in the affected eye, and an intraocular pressure (IOP) was 8 mmHg. She underwent surgical revision involving bleb excision, conjunctival reapproximation, and application of 70% isopropyl alcohol to de-epithelialized corneal tissue to reduce the risk of recurrence. Postoperatively, the bleb was well formed, IOP remained stable at 10 mmHg without any IOP-lowering medications, and the patient reported significant cosmetic improvement. No complications or recurrences were observed at the 1-year follow-up. CONCLUSIONS This case highlights a potential role for isopropyl alcohol in the surgical revision of OFB. The technique was associated with a favorable functional and cosmetic outcome. Further studies are warranted to assess its long-term efficacy and broader applicability in glaucoma surgery.

Indexed as

2-PropanolBlisterPostoperative ComplicationsTrabeculectomyAdolescentFemaleGlaucomaHumansReoperationVisual Acuity2-Propanol

Identifiers

PMID40394876
PMCPMC12108552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.